Impact of the Severity of Liver Injury in COVID-19 Patients Admitted to an Intensive Care Unit During the SARS-CoV2 Pandemic Outbreak

1Fan Z, Chen L, Li J et al. Clinical features of COVID-19-related liver functional abnormality. Clin. Gastroenterol. Hepatol 2020;18(7):1561-6.Fan Z Chen L Li J et al Clinical features of COVID-19-related liver functional abnormality Clin. Gastroenterol. Hepatol 202018 7 1561 610.1016/j.cgh.2020.04.002Search in Google Scholar

2https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020Search in Google Scholar

3http://www.ms.ro/coronavirus-covid-19/http://www.ms.ro/coronavirus-covid-19/Search in Google Scholar

4https://www.worldometers.info/coronavirus/#countrieshttps://www.worldometers.info/coronavirus/#countriesSearch in Google Scholar

5Qingxian C, Deliang H, Hong Y, et al. COVID-19: abnormal liver function tests. J Hepatol. 2020; Sep: 566-74. doi:/10.1016/j.jhep.2020.04.006Qingxian C Deliang H Hong Y et al COVID-19: abnormal liver function tests J Hepatol 2020 Sep 566 74 doi:/10.1016/j.jhep.2020.04.006Open DOISearch in Google Scholar

6Wang D, Hu B, Hu C,et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA.2020; 323 (11): 1061-1069. doi:10.1001/jama.2020.1585Wang D Hu B Hu C et al Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA.2020; 323 11 1061 1069 10.1001/jama.2020.1585Open DOISearch in Google Scholar

7Xiaolong Q, Chuan L, Jiang Z, et al. Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury. J Hepatol. 2020; 73(2): 455–458. doi: 10.1016/j.jhep.2020.04.010Xiaolong Q Chuan L Jiang Z et al Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury J Hepatol 2020 73 2 455 458 10.1016/j.jhep.2020.04.010Open DOISearch in Google Scholar

8Andrade RJ, Chalasani N, Bjornsson ES, et al. Drug-induced liver injury. Nature Reviews Disease Primers. 2019; 5(1): 1-22.Andrade RJ Chalasani N Bjornsson ES et al Drug-induced liver injury Nature Reviews Disease Primers 2019 5 1 1 2210.1038/s41572-019-0105-0Search in Google Scholar

9Chaolin H, Yeming W, Xingwang L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.The Lancet. 2020; 395.10223: 497-506. https://doi. org/10.1016/S0140-6736(20)30183-5Chaolin H Yeming W Xingwang L et al Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.The Lancet. 2020; 395 10223 497 506 10.1016/S0140-6736(20)30183-5Open DOISearch in Google Scholar

10Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International immunopharmacology. 2020;106504. https://doi.org/10.1016/j.intimp.2020.106504Yang AP Liu JP Tao WQ et al The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients International immunopharmacology 2020106504 10.1016/j.intimp.2020.106504715292432304994Open DOISearch in Google Scholar

11Henry BM, Santos de Oliveira MH, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 2020; 58.7: 1021-1028. https://doi. org/10.1515/cclm-2020-0369Henry BM Santos de Oliveira MH Benoit S et al Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 2020; 58 7 1021 1028 10.1515/cclm-2020-036932286245Open DOISearch in Google Scholar

12Yueying L, Xiao SY. Hepatic involvement in COVID‐19 patients: pathology, pathogenesis and clinical implications. Journal of medical virology. 2020; https://doi.org/10.1002/jmv.25973Yueying L Xiao SY Hepatic involvement in COVID‐19 patients: pathology, pathogenesis and clinical implications Journal of medical virology 2020 10.1002/jmv.2597332369204Open DOISearch in Google Scholar

13Wiersinga WJ, Rhodes A, Cheng CA, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. Jama. 2020; 324.8: 782-793. doi:10.1001/jama.2020.12839Wiersinga WJ Rhodes A Cheng CA et al Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. Jama. 2020; 324 8 782 793 10.1001/jama.2020.1283932648899Open DOISearch in Google Scholar

14Gupta A, Mandhavan M, Landry D, et al. Extrapulmonary manifestations of COVID-19. Nature medicine. 2020; 26.7: 1017-1032. https://doi.org/10.1038/s41591-020-0968-3.Gupta A Mandhavan M Landry D et al Extrapulmonary manifestations of COVID-19 Nature medicine 2020 26 7 1017 1032 10.1038/s41591-020-0968-332651579Open DOISearch in Google Scholar

15Bertolini A, Van de Peppel PI, Bodewes F et al. Abnormal liver function tests in COVID‐19 patients: relevance and potential pathogenesis. Hepatology. 2020; 72(5):1864-1872 https://doi.org/10.1002/hep.31480Bertolini A Van de Peppel PI Bodewes F et al Abnormal liver function tests in COVID‐19 patients: relevance and potential pathogenesis Hepatology 2020 72 5 1864 1872 10.1002/hep.31480740441432702162Open DOISearch in Google Scholar

16Bloom PP, Trisha SP, Viveiros K. We know liver biochemistries are elevated in COVID-19, but should we be concerned?. Clinical Gastroenterology and Hepatology. 2020; 18.10: 23842385. https://doi.org/10.1016/j.cgh.2020.05.018Bloom PP Trisha SP Viveiros K We know liver biochemistries are elevated in COVID-19, but should we be concerned? Clinical Gastroenterology and Hepatology 2020 18 10 23842385 10.1016/j.cgh.2020.05.018722974532425706Open DOISearch in Google Scholar

17Alqahtani SA, Jörn MS. Liver injury in COVID-19: The current evidence. United European Gastroenterology Journal. 2020; 8.5: 509-519. https://doi.org/10.1177/2050640620924157Alqahtani SA Jörn MS Liver injury in COVID-19: The current evidence United European Gastroenterology Journal 2020 8 5 509 519 10.1177/2050640620924157726894932450787Open DOISearch in Google Scholar

18Ridruejo E, Soza A. The liver in times of COVID-19: What hepatologists should know. Annals of Hepatology. 2020; 19(4):353-358Ridruejo E Soza A The liver in times of COVID-19: What hepatologists should know Annals of Hepatology 2020 19 4 353 35810.1016/j.aohep.2020.05.001723323632425991Search in Google Scholar

19Parohan M, Sajad Y, Asal S. Liver injury is associated with severe Coronavirus disease 2019 (COVID‐19) infection: a systematic review and meta‐analysis of retrospective studies. Hepatology Research.2020; 50(8):924-935. https://doi.org/10.1111/hepr.13510Parohan M Sajad Y Asal S Liver injury is associated with severe Coronavirus disease 2019 (COVID‐19) infection: a systematic review and meta‐analysis of retrospective studies. Hepatology Research 2020 50 8 924 935 10.1111/hepr.13510727309732386449Open DOISearch in Google Scholar

20Boettler T, Newsome PN, Mondelli MU, et al. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Reports. 2020; 2(3):100113. https://doi. org/10.1016/j.jhepr.2020.100113Boettler T Newsome PN Mondelli MU et al Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper JHEP Reports 2020 2 3 100113 10.1016/j.jhepr.2020.100113712847332289115Open DOISearch in Google Scholar

21Jiang S , Wang R, Li L, et al. Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study. Frontiers in medicine. 2020; 7:347. https://doi.org/10.3389/fmed.2020.00347Jiang S Wang R Li L et al Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study Frontiers in medicine 2020 7347 10.3389/fmed.2020.00347732479432656222Open DOISearch in Google Scholar

22Bubenek S, Filipescu D, Grigoras I, et al. Ghid Societatea Romană de Anestezie și Terapie Intensivă – Terapia Intensivă a pacientului critic cu boală COVID-19 in secțiile ATI .2020. pp.30-38Bubenek S Filipescu D Grigoras I et al Ghid Societatea Romană de Anestezie și Terapie Intensivă – Terapia Intensivă a pacientului critic cu boală COVID-19 in secțiile ATI 2020 pp 30 38Search in Google Scholar

23Zheng Y, Song B. COVID-19 related liver injury: call for international consensus. Clinical Gastroenterology and Hepatology. 2020; 18(12): 2848–2851. https://doi. org/10.1016/j.cgh.2020.05.Zheng Y Song B COVID-19 related liver injury: call for international consensus Clinical Gastroenterology and Hepatology 2020 18 12 2848 2851 10.1016/j.cgh.2020.05Open DOISearch in Google Scholar